In this case, the TMS mixture was comprised of dimethylformamide and decane; however, these solvents were not rigorously screened and may represent a suboptimal solution for catalyst recovery.
The standard assay mixture was comprised of 2.5 ml, 125 mM 3-quinuclidinone-HCl, 350 μM NADPH, and 200 mM potassium phosphate buffer (pH 7.0), and the appropriate amount of the purified enzyme.
The commercially available standard Dyn-MRM kit mixture was comprised of about 24 drugs (codeine, oxycodone, amphetamine, methamphetamine, MDA, MDMA, MDEA, hydrocodone, strychnine, cocaine, heroin, meperidine, trazodone, PCP, oxazepam, nitrazepam, verapamil, methadone, lorazepam, alprazolam, temazepam, proadifen, diazepam and THC).
In brief, the reaction mixture was comprised of 5 mM NADH, 50 mM ATP, 50 mM phosphocreatine, 0.2 mM NaHCO3, 100 mM Tris HCl buffer (pH 7.8), 12 mM MgCl2, 0.4 mM EDTA Na2, 160 U mL−1 3-phosphoglycerate kinase, glyceraldehyde-3-phosphate dehydrogenase, creatine phosphokinase, and 0.1 mL enzyme extract solution.
The reaction mixture was comprised of 50 mM KPi (pH 7.5) and 0.1 mg/ml bovine serum albumin, 125 µM NADPH, and 60 µM 2-trans-hexenoyl-CoA that was synthesized by way of the mixed anhydride system [51] as the substrate.
* The tester mixture was comprised of 90 sorghum genotypes without the four parental genotypes (ICSV745, B90562, R31945-2-2 and IS 8525).
Reaction mixtures were comprised of 0.1 M sodium phosphate buffer (pH7.4) containing increasing 10% (v/v) increments of organic solvent.
The reaction mixture (25 μl final volume) was comprised of 1 x AMV / Tfl reaction buffer, 0.2 μM of each dNTP, 0.4 μM of each forward (F) and reverse (R) primer, 1 mM MgSO4, 0.1 units (U) of AMV reverse transcriptase, 0.1 U Tfl DNA polymerase and 200 ng of RNA template.
The fibrous tissue was comprised of a mixture of immature and mature connective tissue matrix, with the more mature fibrosis indicated by dense collagen fibers with trabecular meshwork.
The final dataset was comprised of a mixture of cross-sectional and longitudinal data.
One consisted predominantly of benign tumours, one contained mostly malignant tumours, and one was comprised of a mixture of borderline and malignant tumours.
